BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21652058)

  • 21. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
    Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
    Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome.
    Alos L; Moyano S; Nadal A; Alobid I; Blanch JL; Ayala E; Lloveras B; Quint W; Cardesa A; Ordi J
    Cancer; 2009 Jun; 115(12):2701-9. PubMed ID: 19365846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.
    Allo G; Yap ML; Cuartero J; Milosevic M; Ferguson S; Mackay H; Kamel-Reid S; Weinreb I; Ghazarian D; Pintilie M; Clarke BA
    Int J Gynecol Pathol; 2020 Jul; 39(4):391-399. PubMed ID: 31274700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
    Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
    Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
    Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
    Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.
    Steinestel J; Al Ghazal A; Arndt A; Schnoeller TJ; Schrader AJ; Moeller P; Steinestel K
    BMC Cancer; 2015 Apr; 15():220. PubMed ID: 25885064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
    Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva.
    de Sanjosé S; Alemany L; Ordi J; Tous S; Alejo M; Bigby SM; Joura EA; Maldonado P; Laco J; Bravo IG; Vidal A; Guimerà N; Cross P; Wain GV; Petry KU; Mariani L; Bergeron C; Mandys V; Sica AR; Félix A; Usubutun A; Seoud M; Hernández-Suárez G; Nowakowski AM; Wilson G; Dalstein V; Hampl M; Kasamatsu ES; Lombardi LE; Tinoco L; Alvarado-Cabrero I; Perrotta M; Bhatla N; Agorastos T; Lynch CF; Goodman MT; Shin HR; Viarheichyk H; Jach R; Cruz MO; Velasco J; Molina C; Bornstein J; Ferrera A; Domingo EJ; Chou CY; Banjo AF; Castellsagué X; Pawlita M; Lloveras B; Quint WG; Muñoz N; Bosch FX;
    Eur J Cancer; 2013 Nov; 49(16):3450-61. PubMed ID: 23886586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma.
    Rosenthal AN; Hopster D; Ryan A; Jacobs IJ
    Br J Cancer; 2003 Jan; 88(2):251-6. PubMed ID: 12610510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vulvar cancer: Two pathways with different localization and prognosis.
    Hinten F; Molijn A; Eckhardt L; Massuger LFAG; Quint W; Bult P; Bulten J; Melchers WJG; de Hullu JA
    Gynecol Oncol; 2018 May; 149(2):310-317. PubMed ID: 29555332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.
    Lérias S; Esteves S; Silva F; Cunha M; Cochicho D; Martins L; Félix A
    Mod Pathol; 2020 May; 33(5):893-904. PubMed ID: 31844270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
    da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy.
    Horne ZD; Dohopolski MJ; Pradhan D; Bhargava R; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks MB; Bockmeier MM; Berger JL; Taylor SE; Sukumvanich P; Beriwal S
    Gynecol Oncol; 2018 Oct; 151(1):96-101. PubMed ID: 30082072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis.
    Ferrándiz-Pulido C; Masferrer E; de Torres I; Lloveras B; Hernandez-Losa J; Mojal S; Salvador C; Morote J; Ramon y Cajal S; Pujol RM; Garcia-Patos V; Toll A
    J Am Acad Dermatol; 2013 Jan; 68(1):73-82. PubMed ID: 22863066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma.
    Lavorato-Rocha AM; Rodrigues IS; de Melo Maia B; Stiepcich MM; Baiocchi G; Carvalho KC; Soares FA; Vassallo J; Rocha RM
    Tumour Biol; 2013 Dec; 34(6):3713-20. PubMed ID: 23832541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.
    Näsman A; Nordfors C; Grün N; Munck-Wikland E; Ramqvist T; Marklund L; Lindquist D; Dalianis T
    Cancer Med; 2013 Aug; 2(4):507-18. PubMed ID: 24156023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.